Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

PREMIER Biosoft and PamGene International BV form an alliance

Released on = February 20, 2007, 11:23 am

Press Release Author = Neil Watson

Industry = Biotech

Press Release Summary = PREMIER Biosoft International today, February 15, 2007,
announced an alliance with PamGene International B.V. to develop a software product
for designing custom MLPA® oligonucleotide probes for use with PamChip® microarrays.


Press Release Body = Palo Alto, California-February 15th 2007. PREMIER Biosoft
International, a leading bioinformatics company, and PamGene International B.V.,
owner of patented technologies for second-generation microarray products, have come
together to develop a software tool to design custom oligos for use in MLPA® based
assays.

Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method for assessing
tens to hundreds of gene copy number changes, single-nucleotide polymorphisms
(SNPs), insertions and deletions and methylation markers in genomic DNA in a single
reaction tube. PamGene's microarray platform detects and quantifies all these MLPA®
amplified products with a single array using its flow-through PamChip® microarrays
and PamStation® systems.

The alliance will help MLPA® users design custom oligos for use with PamGene\'s
microarrays. Currently, such a tool is not available to the users. \"I see great
synergies between the two companies. I look forward to working with PamGene to
develop such an innovative product\", commented Kay Brown, V.P. Business Development
and Marketing of PREMIER Biosoft. Rinie van Beuningen, V.P. Business Development,
PamGene International added, "With this software tool we are enabling researchers to
quickly develop new multiplex genomic assays for use in research and diagnostics".

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular
biologists dedicated to producing cutting-edge intuitive software for the molecular
biologist. The goal of the company is to study the most recent innovations in
molecular biology and translate them into software products that aid biologists.
Additional information about PREMIER Biosoft International is available at
http://www.PremierBiosoft.com.

About PamGene International
PamGene is a European biotechnology company that owns patented technologies for
second-generation microarray products including an innovative transcription
profiling system. Its array-based MLPA application, based on Jan Schouten's
discovery in 2002 and using reagents provided by MRC-Holland, accelerates a number
of genomic assays. PamGene's technology and products are for use in pharma-biotech
R&D and production, academic research, non-pharma life sciences and health
management testing applications. More information about PamGene International can be
found at http://www.pamgene.com/


Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com


Web Site = http://www.PremierBiosoft.com

Contact Details = PREMIER Biosoft International
3786, Corina Way, Palo Alto
California, USA
Zip: 94303-4504
Phone: 650-856-2703
Fax: 650-618-1773
Email: support@premierbiosoft.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •